Found 300 matching trials
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis PHASE3 This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Show More Location
Istituto Giannina Gaslini
Learn More & Join Trial
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant PHASE1 This phase I trial studies the best dose and how well bendamustine works wi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies how well imatinib mesylate works in...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation PHASE4 The goal of the present study is to evaluate if addition of methotrexate ca...
Show More Location
The E. Wolfson.Medical Center
Learn More & Join Trial
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma PHASE2 Objectives:
A. Primary objective:
1 To assess the feasibility and the eff...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant PHASE2 This is a phase II open label trial designed to evaluate the efficacy of Ta...
Show More Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention PHASE3 This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Show More Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Learn More & Join Trial
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL PHASE1 In the proposed study, escalating doses of inotuzumab ozogamicin will be ad...
Show More Location
Vanderbilt-Ingram Cancer Center
Learn More & Join Trial
A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis PHASE4 A Canadian study to evaluate early use of adalimumab after methotrexate fai...
Show More Location
Multiple Locations
Learn More & Join Trial
Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma PHASE1 This research study is assessing the feasibility of reduced intensity allog...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial